Literature DB >> 3799886

Protection of the small intestine from nonocclusive mesenteric ischemic injury due to cardiogenic shock.

R W Bailey, G B Bulkley, S R Hamilton, J B Morris, U H Haglund.   

Abstract

In a pericardial tamponade model of cardiogenic shock in pigs, we had previously shown that acute reductions in cardiac output produce severe mesenteric ischemia due to disproportionate splanchnic vasoconstriction. In this study, we extended the period of cardiogenic shock in order to investigate the pathogenesis of ischemic injury to the small intestinal wall. Four hours of tamponade produced sustained changes in splanchnic hemodynamics, similar to those observed in the prior short-term experiments. The resultant mesenteric ischemia caused necrotic lesions of the small intestine which were characteristic of those seen in nonocclusive mesenteric ischemia in human subjects. Prior alpha-adrenergic blockade failed to prevent either sustained mesenteric vasospasm or ischemic injury. In contrast, prior blockade of the renin-angiotensin axis, whether by nephrectomy or angiotensin-converting enzyme inhibition, blocked the splanchnic vasoconstriction, and thereby protected the small intestine from ischemic injury. The primary hemodynamic and pathologic features of this model of nonocclusive mesenteric ischemia appear to be mediated by the renin-angiotensin axis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3799886     DOI: 10.1016/0002-9610(87)90210-8

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  20 in total

1.  Reperfusion in non-occlusive mesenteric ischaemia (NOMI): effectiveness of CT in an emergency setting.

Authors:  Maria A Mazzei; Susanna Guerrini; Nevada Cioffi Squitieri; Carla Vindigni; Giusi Imbriaco; Francesco Gentili; Daniela Berritto; Francesco G Mazzei; Roberto Grassi; Luca Volterrani
Journal:  Br J Radiol       Date:  2016-02-05       Impact factor: 3.039

Review 2.  Current theories of pathogenesis and treatment of nonocclusive mesenteric ischemia.

Authors:  M G Wilcox; T J Howard; L A Plaskon; J L Unthank; J A Madura
Journal:  Dig Dis Sci       Date:  1995-04       Impact factor: 3.199

Review 3.  Gut ischaemia.

Authors:  U Haglund
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

Review 4.  Splanchnic ischaemia and multiple organ failure in the critically ill.

Authors:  R G Fiddian-Green
Journal:  Ann R Coll Surg Engl       Date:  1988-05       Impact factor: 1.891

5.  Effect of prolonged selective intramesenteric arterial vasodilator therapy on intestinal viability after acute segmental mesenteric vascular occlusion.

Authors:  J E Meilahn; J B Morris; E P Ceppa; G B Bulkley
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

6.  Endotoxic shock after long-term resuscitation of hemorrhage/reperfusion injury decreased splanchnic blood flow and eicosanoid release.

Authors:  S I Myers; R H Tumage; K M Kadesky; A R Seelig; L Bartula
Journal:  Ann Surg       Date:  1996-08       Impact factor: 12.969

7.  [Significance of therapy timing for the effects of systemic and local therapy with the ACE inhibitor captopril on intestinal microcirculation in manifest mesenteric ischemia. An animal experiment study in the swine].

Authors:  J Jakschik; P Decker; A Hirner
Journal:  Langenbecks Arch Chir       Date:  1995

8.  The fundamental hemodynamic mechanism underlying gastric "stress ulceration" in cardiogenic shock.

Authors:  R W Bailey; G B Bulkley; S R Hamilton; J B Morris; U H Haglund; J E Meilahn
Journal:  Ann Surg       Date:  1987-06       Impact factor: 12.969

9.  Survival in nonocclusive mesenteric ischemia: early diagnosis by multidetector row computed tomography and early treatment with continuous intravenous high-dose prostaglandin E(1).

Authors:  Akira Mitsuyoshi; Kazutaka Obama; Nobuhiko Shinkura; Takashi Ito; Masazumi Zaima
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

10.  Changes in regional blood flow and pCO(2) gradients during isolated abdominal aortic blood flow reduction.

Authors:  Rafael Knuesel; Stephan M Jakob; Lukas Brander; Hendrik Bracht; Andreas Siegenthaler; Jukka Takala
Journal:  Intensive Care Med       Date:  2003-09-17       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.